A r t i c l e s DNA methylation is a heritable epigenetic mark that is critical for mammalian development [1] [2] [3] [4] [5] . DNA methylation state at the promoters of many developmental regulators such as Pou5f1 (Oct4) is correlated with stable silencing of these genes during development, and overcoming this barrier is believed to be a key step during cellular reprogramming 1, 2, 6, 7 . Recent genome-wide analysis of DNA methylation in human cells has identified a widespread distribution of this epigenetic mark and, paradoxically, has shown hypermethylation in the gene bodies of actively transcribed genes 8, 9 . More recently, hypomethylation has also been found at active enhancers 9,10 . Together, these studies have underscored the diverse roles that DNA methylation has in gene regulation and the need for systematic mapping and characterization of DNA methylomes in different tissues and cell types.
A r t i c l e s DNA methylation is a heritable epigenetic mark that is critical for mammalian development [1] [2] [3] [4] [5] . DNA methylation state at the promoters of many developmental regulators such as Pou5f1 (Oct4) is correlated with stable silencing of these genes during development, and overcoming this barrier is believed to be a key step during cellular reprogramming 1, 2, 6, 7 . Recent genome-wide analysis of DNA methylation in human cells has identified a widespread distribution of this epigenetic mark and, paradoxically, has shown hypermethylation in the gene bodies of actively transcribed genes 8, 9 . More recently, hypomethylation has also been found at active enhancers 9, 10 . Together, these studies have underscored the diverse roles that DNA methylation has in gene regulation and the need for systematic mapping and characterization of DNA methylomes in different tissues and cell types.
The DNA methylome is remodeled extensively during mammalian development and in different tissue lineages 11, 12 . Previous studies, employing mainly technologies that examine a subset of the genome, have identified many tsDMRs 13 . These regions are located in intergenic sequences and seem to be most variably methylated in cancer cells 14 . However, owing to limited resolution and the absence of functional annotation data, the identities and biological roles of these previously identified tsDMRs remain unclear. Recent progress in the functional annotation of the mouse genome provides an opportunity to characterize tsDMRs and link dynamic methylation to gene expression patterns in different tissues. Further, advances in base-resolution analysis of DNA methylomes permit a more comprehensive definition of tsDMRs in the genome.
To explore epigenetic variation in normal tissues, we performed shallow sampling of the methylomes of 17 mouse tissues spanning all 3 germ layers and extraembryonic placenta. Given this limited set of tissues and sequencing depth, we estimate that tsDMRs span at least 6.7% of the genome. tsDMRs are short regions that are hypomethylated in a small number of tissues and are predominantly localized to regulatory elements. Furthermore, we uncover a class of tsDMRs that are inactive in adult tissues but active during development, suggesting that some enhancers retain an epigenetic memory of their developmental history and can be identified in adult cells by virtue of their DNA hypomethylation status.
RESULTS

Whole-genome bisulfite sequencing of 17 mouse tissues
To create unbiased genome-wide maps of DNA methylation, we performed whole-genome bisulfite sequencing in 17 tissues spanning all 3 germ layers and extraembryonic placenta derived from a single pregnant female mouse. We sequenced to an average depth of 8.2-fold genomic coverage per tissue ( Supplementary Fig. 1a ), spanning on average 79.7% of the CpG dinucleotides in the mouse genome ( Supplementary Fig. 1b ). Sequencing of control unmethylated λ DNA spiked into each sample verified efficient bisulfite conversion averaging 99.4%.
Somatic methylomes appeared concordant on a >100-kb scale via visual examination ( Fig. 1a) : in general, the genome was highly methylated, with occasional drops in methylation corresponding with CpG islands. For example, the CpG-rich Hoxa locus, as well as the CpG island-containing promoters for Skap2 and Evx1, were uniformly demethylated in most somatic tissues compared with surrounding regions. To examine the global distribution of DNA methylation, Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues Gary C Hon 1 
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Mammalian development requires cytosine methylation, a heritable epigenetic mark of cellular memory believed to maintain a cell's unique gene expression pattern. However, it remains unclear how dynamic DNA methylation relates to cell type-specific gene expression and animal development. Here, by mapping base-resolution methylomes in 17 adult mouse tissues at shallow coverage, we identify 302,864 tissue-specific differentially methylated regions (tsDMRs) and estimate that >6.7% of the mouse genome is variably methylated. Supporting a prominent role for DNA methylation in gene regulation, most tsDMRs occur at distal cis-regulatory elements. Unexpectedly, some tsDMRs mark enhancers that are dormant in adult tissues but active in embryonic development. These 'vestigial' enhancers are hypomethylated and lack active histone modifications in adult tissues but nevertheless exhibit activity during embryonic development. Our results provide new insights into the role of DNA methylation at tissue-specific enhancers and suggest that epigenetic memory of embryonic development may be retained in adult tissues.
was globally elevated in ectodermal tissues relative to other somatic tissues ( Supplementary Fig. 1c,d ) and overlapped significantly (P CHG < 1 × 10 −15 , P CHH < 1 × 10 −15 , normal distribution; overlap of random regions is normally distributed, Shapiro-Wilk test) ( Supplementary  Fig. 1e ) with regulatory elements (Supplementary Fig. 1f ). PMDs are large genomic regions (>10 kb in length) of depleted DNA methylation (<70% mCG) typically found in somatic cell lines 9, 21 and tumor cells 22 . Using a hidden Markov model (HMM) approach to segment the genome of each tissue into methylation domains (Online Methods), we indeed observed large domains with intermediate levels of methylation ( Supplementary Fig. 2a,b ) that spanned a significantly (P = 0.0036, Wilcoxon) greater percentage of non-ectodermal somatic tissues (average of 67.7%) than ectodermal tissues (average of 36.4%) ( Fig. 1e) . These regions overlapped in non-ectodermal tissues significantly more often than expected by chance (P < 1 × 10 −15 , Wilcoxon) ( Supplementary Fig. 2c-e ). Consistent with previous observations 22 , these pre-PMDs contained more DNA methylation than classically defined PMDs 9 , but, like PMDs, they overlapped extensively with lamina-associated 23 and late-replicating 24 domains ( Supplementary Fig. 2f ).
Identification of tsDMRs
The above analysis suggests that tissue-specific DNA methylation patterns reflect cell lineage identity. To comprehensively identify tsDMRs, we devised a χ 2 -based statistic to capture tissue-specific DNA methylation in the CpG context and employed an HMM on this statistic to segment the genome ( Fig. 2a and Online Methods). 
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This analysis excluded the globally hypomethylated placenta. Visual inspection indicated that tsDMRs were distributed throughout the genome as small, discrete segments. For example, near the ubiquitously expressed Wipf2 gene, we identified eight tsDMRs, each hypomethylated in a unique subset of tissues ( Fig. 2b) . Interestingly, Wipf2 is most highly expressed in brain tissue, and several tsDMRs (sites 2, 3 and 7) were specifically hypomethylated in ectodermal tissue, raising the possibility that these tsDMRs might be involved in the regulation of Wipf2.
Altogether, the initial HMM segmentation identified 341,975 potential tsDMRs (with high tissue specificity) ( Fig. 2c ) at a false discovery rate (FDR) of 3.96 × 10 −5 . The median length of tsDMRs was 454 bp, significantly shorter than for regions having low tissue specificity (non-tsDMRs; median length of 1,290 bp; P < 1 × 10 −15 , Wilcoxon) ( Fig. 2d and Supplementary Fig. 3a ). In addition, the average methylation level of tsDMRs across tissue samples (60.4%) was significantly lower than for non-tsDMRs (82.8%) (P < 1 × 10 −15 , Wilcoxon), and the variance in methylation was significantly greater in tsDMRs (P < 1 × 10 −15 , Wilcoxon) ( Fig. 2e and Supplementary  Fig. 3b ). These results suggest that tsDMRs are short genomic elements that are hypomethylated in a tissue-specific manner in a larger background of large non-tsDMRs that are uniformly highly methylated. Next, we filtered tsDMRs to those that exhibited high variance in tissue methylation and significant tissue specificity. This filtering yielded 302,864 high-confidence tsDMRs ( Supplementary Table 1 ), which we analyzed further. Given our limited selection of tissues and sequencing depth, we estimate that at least 6.7% of the mouse epigenome is variably methylated in adult tissue.
Tissue-specific DMRs are predominantly regulatory elements
Previous analyses of tissue-specific DMRs showed that these regions are largely intergenic and that their DNA methylation state is highly variable among different cell types. However, it was unclear what functions these regions might carry out 13 . A recent study examining DNA methylation in mouse ES cells and neural precursors found that regions with low methylation demonstrated features of distal regulatory elements and corresponded with cell type-specific transcription factor binding sites 10 . We therefore investigated the possibility that the tsDMRs identified here might correspond with cisregulatory elements by comparing them to publicly available genomic annotations. Consistent with an epigenetic signature at active enhancers [25] [26] [27] , in liver, the histone modifications 28 monomethylation of histone H3 at lysine 4 (H3K4me1) and acetylation of histone H3 at lysine 27 (H3K27ac) (but not promoter-specific trimethylation of histone H3 at lysine 4, H3K4me3) were abundant (log 2 (chromatin immunoprecipiatation (ChIP)/input) > 1)) and were more enriched for liverspecific tsDMRs than for non-liver-specific tsDMRs ( Fig. 3a and Supplementary Figs. 3b and 4) . Both active and poised 27, 29, 30 enhancers showed hypomethylation ( Supplementary Fig. 5a ). In addition, tsDMRs were hypomethylated ( Fig. 3a and Supplementary Fig. 4 ) and evolutionarily conserved 31 ( Fig. 3b and Supplementary Fig. 4 ). Given our current sequencing depth, we found that the vast majority of tsDMRs (average of 74.2%) were near known distal regulatory elements (enhancers and CTCF-binding sites) ( Fig. 3c, right) . Furthermore, as the remaining tsDMRs are highly conserved (Supplementary Fig. 5c ) and enriched in sequence motifs of known transcription factors ( Supplementary Table 2 ), they are likely regulatory elements that have escaped current detection methods. Consistent with the expectation that enhancers are highly cell type specific, the vast majority of tsDMRs were specifically hypomethylated in either one or two tissues (Fig. 3c, left and Supplementary  Fig. 5b) , and instances of tsDMR hypomethylation in multiple tissues were generally confined to tissues of the same lineage. A recent report documented that evolutionary conservation of gene expression levels in mammals depends on tissue type, with tissues of the nervous system showing the most conservation 32 . In agreement with this observation, we found that evolutionary conservation of both promoter-proximal and promoter-distal tsDMRs (Fig. 4a,b) was also dependent on cell lineage, with ectodermal tissues being most conserved, followed by mesodermal tissues. Notably, distal regulatory elements of the uterus were significantly more conserved than those of other mesodermal tissues (P heart < 1 × 10 −15 , P kidney < 1 × 10 −15 , P skin < 1 × 10 −15 , Wilcoxon test on all PhastCons scores within 100 bp of a tsDMR CpG), which attests to the evolutionary importance of the uterus.
To further show that tsDMRs are regulatory sequences, we examined them for the enrichment of transcription factor binding motifs 33 . Indeed, consensus motifs for known lineage-specific master regulators were significantly enriched at tsDMRs found in the specific tissues ( Fig. 5 and Supplementary Fig. 4 ). For example, motifs for the hematopoietic transcription factors SPI1/PU.1and RUNX1 were specifically enriched in tsDMRs found in blood-producing organs, the endodermal forkhead transcription factor FOXA1 was most enriched in tsDMRs found in endodermal tissues, and the neuronal differentiation factors NEUROD1 and MEF2A were significantly enriched in tsDMRs found in ectodermal tissues. The above results indicate that the vast majority of tissue-specific DMRs correspond with cis-regulatory elements in each tissue. Similar analysis showed that regions with intermediate, tissue-specific DNA methylation exhibited weaker enrichment of active chromatin, evolutionary conservation, distal regulatory elements and tissue-specific motifs ( Supplementary Fig. 3c-f) .
To assess the resolution of tsDMRs in predicting enhancers, we made comparisons with approaches involving chromatin immunoprecipitation and sequencing (ChIP-seq) of histone modifications 25, 26, 28 or the transcriptional coactivator p300 (refs. 25, 26, 34) . In heart, we identified a common set of regulatory elements that were identified by all methods and searched for motifs in common loci for factors specific to the tissue. We found that, whereas all methods identified a clustering of tissue-specific motifs near the predicted site of a regulatory element, p300-binding sites and tsDMRs showed the highest degree of clustering, and enhancers predicted by chromatin modifications demonstrated the least (Fig. 5b) . To more precisely quantify resolution, we calculated the cumulative distribution of distance between tissue-specific motif occurrences and predicted regulatory sites for distances less than 500 bp. We then defined d 50 as the distance in which 50% of motif occurrences were within the set of predicted regulatory sites. Thus, small values of d 50 indicate higher resolution, with 250 bp indicative of a null model. In heart, d 50 values for p300binding sites (189 bp) and tsDMRs (191 bp) were clearly separated from those for chromatin-predicted enhancers (243 bp) ( Fig. 5c) . These results suggest that identifying tsDMRs is an alternative method to define putative regulatory elements at high resolution in vivo. However, identifying enhancers using tsDMRs requires the presence of CpG sequences, thus precluding the identification of enhancers with no CpGs (Supplementary Fig. 6c and Supplementary Note). Future work using greater depth will be required to identify tsDMRs in CpG-poor regions and to assess their genomic functions.
Some tsDMRs correspond with dormant developmental enhancers
Many tsDMRs identified in adult tissues were marked by H3K4me1 and H3K27ac in the same tissue ( Fig. 3a) , but a closer examination npg A r t i c l e s showed a gradient of active chromatin, with some tsDMRs exhibiting an inactive chromatin state (Fig. 6a) . For the ten tissues with available histone modification ChIP-seq data 28 , we therefore used chromatin to partition tsDMRs into two distinct groups-those that contained active chromatin (ADult-Active tsDMRs, denoted AD-A tsDMRs) and those that did not (ADult-Inactive tsDMRs, denoted AD-I tsDMRs) ( Fig. 6b , Online Methods and Supplementary Table 3 ). Both groups of enhancers were depleted of DNA methylation (Fig. 6b) .
Given the lack of active chromatin features at AD-I tsDMRs, we wondered whether these regions potentially represent false predictions. To test this possibility, we searched for known motifs specific to either AD-A or AD-I tsDMRs in each tissue, reasoning that false predictions would not be enriched for motifs. AD-A tsDMR-specific motifs were enriched for binding sites for transcription factors found in differentiated cells, including the liver regulator HNF1 and the signal transducer STAT3 (Fig. 6c) . Interestingly, AD-I tsDMR-specific motifs belonged to many developmental transcription factors, such as the trophoblast differentiation factor EOMES, members of the HOX family and the neuronal differentiation factor TCF4 (Fig. 6c) . These results held for AD-A and AD-I tsDMRs defined by different cutoffs (Supplementary Fig. 7a,b) . Furthermore, not only did AD-I tsDMRs harbor motifs for developmental factors, but their putative targets were also enriched for developmental genes. Using the GREAT tool 35 on AD-I tsDMRs (Fig. 6d) , we found that more than half of all significantly enriched gene ontology (GO) biological process terms (54.2%) were related to development, compared to the 15.7% found for AD-A tsDMRs. Notably, terms for kidney development, including mesoderm morphogenesis and kidney smooth muscle cell differentiation, were specific to AD-I tsDMRs found in kidney. These results suggest that AD-I tsDMRs may be enhancers of developmental importance. In other words, these regions may correspond with enhancers that are dormant in adult tissues but active during embryonic development.
To test this hypothesis, we first turned to evolutionary conservation. Consistent with the notion that the regulation of developmental gene expression is highly conserved throughout evolution 36 , we found that AD-I tsDMRs in cerebellum and kidney were significantly more conserved than AD-A tsDMRs (P cerebellum < 1 × 10 −15 , P kidney = 1.6 × 10 −127 , Wilcoxon test on all PhastCons scores within 100 bp of a tsDMR CpG; Fig. 6e ). In addition, consistent with a previous study indicating that developmental heart enhancers are less conserved 37 , we found that AD-I tsDMRs were less conserved than AD-A tsDMRs (Fig. 6e) . Next, we focused on AD-I tsDMRs identified in adult cerebellum. Comparing chromatin modifications in adult cerebellum with those in whole brains from embryonic day (E) 14.5 fetuses 28 , we found a significant enrichment of the active enhancer modifications H3K4me1 (P < 1 × 10 −15 , Wilcoxon) and H3K27ac (P < 1 × 10 −15 , Wilcoxon) in fetal tissue compared with adult tissue (Fig. 7a) . Similar observations also held for other tissues of the adult brain (cortex and olfactory bulb) compared with developing brain ( Fig. 7a and Supplementary Fig. 8a ) and for adult heart compared with developing heart (Fig. 7a) : in all cases examined, AD-I tsDMRs in developing tissues were significantly enriched in active enhancer chromatin modifications compared with the same loci in respective adult tissues. In line with the higher levels of active chromatin modifications in developing tissues, genes near AD-I tsDMRs were transcribed at significantly higher levels at early developmental time points than in adult tissues (P = 3.3 × 10 −18 , Wilcoxon) ( Fig. 7b) . These results are reminiscent of previous observations of counteracting epigenetic states in enhancer-promoter pairs 38 .
To further test the hypothesis that AD-I tsDMRs are active in development tissues but dormant in adult tissues, we examined the enrichment of overlap between tsDMRs and enhancers defined by chromatin modifications 28 in a panel of samples spanning ES cells, developing fetuses and adult tissues ( Fig. 7c and Supplementary  Fig. 8b) . AD-I tsDMRs were generally depleted of enhancers in adult tissues but were enriched for enhancers in developing cells. Examining this enrichment statistically, we found that AD-I tsDMRs were significantly more enriched for chromatin-defined enhancers in developmental rather than adult tissue (P = 3.1 × 10 −14 , Wilcoxon) ( Fig. 7d) . Notably, AD-I tsDMRs were most enriched for developmental enhancers in the same lineage. For example, enhancers in E14.5 mouse heart were most enriched for AD-I tsDMRs found in adult mouse heart (Supplementary Fig. 8b) . Similarly, enhancers in E14.5 mouse brain were most enriched at AD-I tsDMRs from the cerebellum, cortex and olfactory bulb. Supporting these observations, comparison of p300-binding sites mapped in E11.5 forebrain and midbrain 34 showed that AD-I tsDMRs in brain were significantly more enriched than in other adult tissues (P forebrain p300, ectoderm AD-I < 1 × 10 −15 , P midbrain p300, ectoderm AD-I < 1 × 10 −15 , normal distribution; Figure 5 Transcription factor binding motif enrichment near tsDMRs. (a) Heatmap representing the enrichment of transcription factor binding motifs for the tsDMRs identified in each tissue. Each row represents a motif, and the corresponding transcription factors for selected motifs are labeled on the right. (b) Predicted regulatory elements in heart (p300-binding sites (gray), chromatinpredicted enhancers (blue), tsDMRs (red)) were overlapped, and the density of known tissue-specific motifs (ETS, FOXO1, GATA4, JUN, MEF2A, NF1, SOX6, STAT3, TEAD4) relative to these aligned intersected sites is shown. (c) Cumulative density of graphs in b with respect to the absolute distance to the predicted regulatory element. The horizontal dashed line indicates 50% cumulative density, and vertical dotted lines indicate the resolution in base pairs of each set of predicted regulatory elements to achieve 50% cumulative density.
overlap of random regions is normally distributed, Shapiro-Wilk test) (Fig. 7e) . These results could also be extended across evolution: mouse cerebellum AD-I tsDMRs that are conserved in humans were more likely to show activity in human fetal brain tissue than in non-brain tissue (Supplementary Fig. 8d) .
To further demonstrate that dormant tsD-MRs are active enhancers during embryonic development, we examined developmental mouse enhancers validated by transgenic mouse assays (VISTA database) 39 . Of the 172 enhancers showing enhancer activity at the E11.5 stage of mouse development, 25 (14.5%) were classified as AD-I tsDMRs. For example, enhancer mm447, showing positive in vivo enhancer activity in E11.5 midbrain (Fig. 7f) , overlapped with an AD-I tsDMR in adult cerebellum that was only 18.2% methylated (Fig. 7g) . This enhancer is within 200 kb of Vax1 (ref. 40) and Emx2 (ref. 41) , two genes encoding critical regulators of brain development that are highly expressed 28 in developing E14.5 brain (RPKM Vax1 = 2.05, RPKM Emx2 = 13.03; RPKM, reads per kilobase of gene per million reads mapped) but not in adult cerebellum (RPKM Vax1 < 0.05, RPKM Emx2 = 0.088). In E14.5 whole brains, mm447 exhibited DNase I hypersensitivity 42 , but this was lost by E18.5 and remained absent in both whole brain and cerebellum from adults. Consistent with this loss of open chromatin, the enhancer was enriched for the active enhancer modifications H3K4me1 and H3K27ac in E14.5 whole brains but not in adult cerebellum 28 . These data support a model in which the enhancer mm447 is active in the midbrain between E11.5 and E14.5, but becomes inactive by E18.5 and remain so in adult brain. However, in both embryonic and adult stages, the enhancer remained hypomethylated. A similar trend also held for another VISTA enhancer, mm414. Thus, the observation that some AD-I tsDMRs demonstrate enhancer activities in early embryos in transgenic assays supports the hypothesis that these sequences are embryonic enhancers.
Taken together, the above results support a model in which some enhancers that are active during development retain an epigenetic memory in adult tissues in the form of DNA hypomethylation. We term these elements vestigial enhancers. Previously, it has been shown that loss of transcription factor binding results in passive 'filling in' of methylation, which would presumably restore vacated enhancers to a fully methylated state 10, 43 . Because vestigial enhancers remain hypomethylated while existing in closed chromatin, the nucleosomes occupying these sequences may be incompatible with DNA methylation. Consistent with this hypothesis, H3K27me3 marks were present at significantly higher levels in vestigial enhancers (AD-I tsDMRs) than in AD-A tsDMRs (Supplementary Fig. 8c ). Previously, it has been shown that DNA methylation is antagonistic to Polycomb complex-mediated histone modifications 21, 44, 45 . Although the exact mechanisms for this antagonism are not yet fully understood, it is npg A r t i c l e s conceivable that Polycomb complexes might be responsible for hypomethylation at vestigial enhancers in adult tissues.
A subset of active developmental enhancers become vestigial
An active developmental enhancer can exist in several epigenetic configurations in adult tissue: it can remain active (H3K4me1 + H3K27ac + mCG − ), become inactive (H3K4me1 − H3K27ac − mCG + ) or become vestigial (H3K4me1 − H3K27ac − mCG − ). To further explore vestigial enhancers in the context of development, we examined 57,298 enhancers with active chromatin marks in the whole brains of E14.5 mouse embryos 28 . In adult brain tissues (cerebellum, cortex and olfactory bulb), we found that the majority of these developmentally active enhancers became inactive (losing active chromatin marks and gaining DNA methylation; average of 50.1%) or remained active (average of 41.2%), whereas the remaining subset (average of 8.6%) lost active chromatin marks and retained hypomethylation (Fig. 8a,b and Supplementary Table 4 ).
The establishment of vestigial enhancers during development can either be a stochastic or regulated event. The fact that vestigial and inactive enhancers both lost active chromatin but one set remained hypomethylated suggests that this is a regulated event. Supporting this notion, different sets of developmental enhancers became vestigial in distinct regions of the adult brain, even though all of these regions were derived from the same developmental tissue (Fig. 8b) . In addition, vestigial enhancers from distinct brain regions were enriched for different sets of developmental motifs (Fig. 8c) , with cerebellum more enriched for members of the GATA and FOX transcription factor families compared with SOX family enrichment in the olfactory bulb.
If the creation of vestigial enhancers is a regulated rather than a stochastic event, then one expectation is that a consistent set of enhancers would become vestigial in different mouse strains. Indeed, we found that the cortex vestigial enhancers identified in our study (in the C57BL/6 strain) were also hypomethylated in the cortices of two additional mice 20 (Cast/129 strains) ( Fig. 8d,e) . The consistency of npg the epigenetic status of vestigial enhancers in diverse strains of mice further underscores the regulated nature of their establishment. The methylomes of these Cast/129 cortices at vestigial enhancers were significantly more similar to those of C57BL/6 cortex than any other C57BL/6 tissue, including other C57BL/6 non-cortical brain tissues (P Cast/129 cortex, C57BL/6 olfactory bulb = 3.29 × 10 −4 , P 129/Cast cortex, C57BL/6 olfactory bulb = 8.06 × 10 −6 , P Cast/129 cortex, C57BL/6 cerebellum = 3.31 × 10 −57 , P 129/Cast cortex, C57BL/6 cerebellum = 1.29 × 10 −62 , Wilcoxon) ( Fig. 8d) . Together, these results support the consistency of vestigial enhancers across different mice from diverse strains and suggest that the unique epigenetic state of vestigial enhancers is created by a regulated event.
DISCUSSION
DNA methylation dynamics have been characterized in mammalian development and in cancer cells 3, 6, 13, 14, 19, 21, 22, [46] [47] [48] . During mammalian development, the genome undergoes two waves of genomewide methylome erasure 49 and re-establishment 11 . In cancer cells, global hypomethylation and local hypermethylation have been well documented 48, 50, 51 . Despite these general observations of the developmental profiles of DNA methylation, it was still unclear how DNA methylomes vary across the wide spectrum of normal tissue types. In profiling the methylomes of a diverse panel of 17 normal adult tissues, we estimate that at least 6.7% of the genome undergoes dynamic methylation in a tissue-specific manner. The identified tsDMRs are generally hypomethylated in a tissue-specific manner. Most notably, these sequences predominantly correspond with distal regulatory elements in the genome.
Although DNA hypomethylation has previously been observed at enhancers 9,10 , the preponderance of tsDMRs corresponding with distal regulatory elements is unexpected. These results raise further questions about the relationship between DNA methylation and enhancer activity. Our observation that vestigial enhancers lack DNA methylation in adult tissues but remain inactive indicates that DNA hypomethylation is not sufficient for enhancer activity. However, it is still unclear whether DNA hypomethylation is required for enhancer activity. Recent evidence that CTCF binding of methylated DNA precedes demethylation suggests that methylation does not impede transcription factor binding 10 . Future studies will be required to precisely define this relationship within the context of DNA hydroxymethylation and demethylation.
It is now clear that, in addition to reflecting the current transcriptional configuration of a cell 25, 52 , the epigenome can also reflect potential future transcriptional states of a cell through the action of poised enhancers 27, 29, 30 . Our observations that a set of enhancers transition from being active during development to being dormant in adult tissues while retaining hypomethylation indicate that, in addition to reflecting the current cellular state, the epigenome can also reflect a cell's past history of activities. As each methylome is derived from another during development and as DNA methylation is faithfully copied during cell division by replication-coupled maintenance methylation 53 , incomplete erasure of a previous developmental state's epigenetic information could potentially be passed on to subsequent generations. In this way, the methylome could potentially be used to unravel the developmental decisions made during differentiation.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. Bisulfite sequencing data sets generated in this study have been deposited in the Gene Expression Omnibus (GEO) under accession GSE42836.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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We thank S. Kuan, Z. Ye and L. Edsall for their assistance in sequencing and the initial processing of sequencing reads. This work is funded by the Ludwig Institute Figure 8 Vestigial enhancers across development and strains. (a) Heatmaps representing the enrichment of chromatin (me1, H3K4me1; ac, H3K27ac) at predicted enhancers with active chromatin in E14.5 mouse brain that consistently retain or lose active chromatin marks in all adult brain tissues (cerebellum, cortex, olfactory bulb). The DNA methylation status in adult tissues is indicated on the right. (b) Percentage of E14.5 mouse brain enhancers belonging to various epigenetic states in adult brain tissue (cer, cerebellum; cor, cortex; olf, olfactory bulb). E14.5 enhancers were overlapped with adult enhancers (A), and the remainder were overlapped with adult tsDMRs (D). The remaining fraction is labeled as inactive (I). (c) Heatmap comparing the enrichment of transcription factor binding motifs for vestigial enhancers in brain tissue T 1 with those in brain tissue T 2 . Each row represents a motif, and several rows are labeled on the right. (d) Top, heatmap of DNA methylation status for various tissues and mouse strains, centered on vestigial enhancers identified in C57BL/6 mouse cortex. Bottom, box plots comparing C57BL/6 cortex vestigial enhancer methylation with that of each tissue or strain. Distance is measured as the absolute difference in methylation of each vestigial enhancer between two tissues. Box plot edges indicate the 25th and 75th percentiles, and whiskers indicate non-outlier extremes. *P < 1 × 10 −3 , Wilcoxon. (e) Average profiles of DNA methylation for cortical tissue from C57BL/6, C/129 and 129/C mice centered at C57BL/6 cortex vestigial enhancers.
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